Skip to main content
SpringerLink
Log in

Assessment of NMDA receptor activation in vivo by Fos induction after challenge with the direct NMDA agonist (tetrazol-5-yl)glycine: effects of clozapine and haloperidol

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Induction of Fos protein by the potent and direct NMDA agonist (tetrazol-5-yl)glycine (TZG) was examined in mice. Effects of antipsychotic drugs were assessed on this in vivo index of NMDA receptor activation. TZG induced the expression of Fos in a neuroanatomically selective manner, with the hippocampal formation showing the most robust response. In mice genetically altered to express low levels of the NR1 subunit of the NMDA receptor, TZG-induced Fos was reduced markedly in comparison to the wild type controls. TZG-induced Fos was also blocked by the selective NMDA antagonist MK-801. Pretreatment of mice with clozapine (3 and 10 mg/kg) reduced TZG-induced Fos in the hippocampal formation but not in other brain regions. Haloperidol at a dose of 0.5 mg/kg did not antagonize TZG induced Fos in any region. Haloperidol at a dose of 1.0 mg/kg did attenuate the induction of Fos by TZG in the hippocampus but not in other brain regions. The relatively high dose (1 mg/kg) of haloperidol required to block effects of TZG suggests that this action may not be related to the D2 dopamine receptor-blocking properties, since maximal D2 receptor blockade was probably achieved by the 0.5 mg/kg dose of haloperidol. The antidepressant drug imipramine (10 or 20 mg/kg) did not antagonize TZG induced Fos in any brain region. The data suggest that clozapine can reduce excessive activation of NMDA receptors by TZG administration in vivo at doses relevant to the drugs’ actions in rodent models of antipsychotic activity. Whether or not this action of clozapine contributes to its therapeutic properties will require further study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Z Abdul-Monim GP Reynolds JC Neill (2006) ArticleTitleThe effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm Behav Brain Res 169 263–273 Occurrence Handle16500717 Occurrence Handle10.1016/j.bbr.2006.01.019 Occurrence Handle1:CAS:528:DC%2BD28XivVCls7w%3D

    Article  PubMed  CAS  Google Scholar 

  • VL Arvanov RY Wang (1999) ArticleTitleClozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine J Pharmacol Exp Ther 289 1000–1006 Occurrence Handle10215680 Occurrence Handle1:CAS:528:DyaK1MXislGisL4%3D

    PubMed  CAS  Google Scholar 

  • VL Arvanov X Liang J Schwartz S Grossman RY Wang (1997) ArticleTitleClozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro J Pharmacol Exp Ther 283 226–234 Occurrence Handle9336328 Occurrence Handle1:CAS:528:DyaK2sXmslCltLo%3D

    PubMed  CAS  Google Scholar 

  • VP Bakshi MA Geyer (1995) ArticleTitleAntagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine Psychopharmacology 122 198–201 Occurrence Handle8848537 Occurrence Handle10.1007/BF02246096 Occurrence Handle1:CAS:528:DyaK2MXhtVSju7rI

    Article  PubMed  CAS  Google Scholar 

  • VP Bakshi NR Swerdlow MA Geyer (1994) ArticleTitleClozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response J Pharmacol Exp Ther 271 787–794 Occurrence Handle7965797 Occurrence Handle1:CAS:528:DyaK2MXisVOqu7o%3D

    PubMed  CAS  Google Scholar 

  • G Bustos J Abarca MI Forray K Gysling CW Bradberry RH Roth (1992) ArticleTitleRegulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: in vivo microdialysis studies Brain Res 585 105–115 Occurrence Handle1355000 Occurrence Handle10.1016/0006-8993(92)91195-K Occurrence Handle1:CAS:528:DyaK38XlsVCis7s%3D

    Article  PubMed  CAS  Google Scholar 

  • R Corbett F Camacho AT Woods LL Kerman RJ Fishkin K Brooks RW Dunn (1995) ArticleTitleAntipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors Psychopharmacology 120 67–74 Occurrence Handle7480537 Occurrence Handle10.1007/BF02246146 Occurrence Handle1:CAS:528:DyaK2MXnsFarsb0%3D

    Article  PubMed  CAS  Google Scholar 

  • M Dragunow RLM Faull (1990) ArticleTitleMk-801 induces C-Fos protein in thalamic and neocortical neurons of rat-brain Neurosci Lett 111 39–45 Occurrence Handle2110635 Occurrence Handle10.1016/0304-3940(90)90341-6 Occurrence Handle1:CAS:528:DyaK3cXitFSqsrY%3D

    Article  PubMed  CAS  Google Scholar 

  • GE Duncan KB Johnson GRT Breese (1993) ArticleTitleTopographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity J Neurosci 13 3932–3943 Occurrence Handle8366353 Occurrence Handle1:CAS:528:DyaK3sXms1Onur8%3D

    PubMed  CAS  Google Scholar 

  • GE Duncan JN Leipzig RB Mailman JA Lieberman (1998a) ArticleTitleDifferential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation Brain Res 812 65–75 Occurrence Handle10.1016/S0006-8993(98)00926-3 Occurrence Handle1:CAS:528:DyaK1cXntVyiu7c%3D

    Article  CAS  Google Scholar 

  • GE Duncan SS Moy DJ Knapp RA Mueller GR Breese (1998b) ArticleTitleMetabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia Brain Res 787 181–190 Occurrence Handle10.1016/S0006-8993(97)01390-5 Occurrence Handle1:CAS:528:DyaK1cXhvFGrtr0%3D

    Article  CAS  Google Scholar 

  • GE Duncan S Miyamoto JN Leipzig JA Lieberman (1999a) ArticleTitleComparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine Brain Res 843 171–183 Occurrence Handle10.1016/S0006-8993(99)01776-X Occurrence Handle1:CAS:528:DyaK1MXmvVGqtLo%3D

    Article  CAS  Google Scholar 

  • GE Duncan S Zorn JA Lieberman (1999b) ArticleTitleMechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia Mol Psychiat 4 418–428 Occurrence Handle10.1038/sj.mp.4000581 Occurrence Handle1:CAS:528:DC%2BD3cXlvVWltb8%3D

    Article  CAS  Google Scholar 

  • GE Duncan S Miyamoto JN Leipzig JA Lieberman (2000) ArticleTitleComparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism J Pharmacol Exp Ther 293 8–14 Occurrence Handle10734147 Occurrence Handle1:CAS:528:DC%2BD3cXkvFGht78%3D

    PubMed  CAS  Google Scholar 

  • GE Duncan S Miyamoto HB Gu JA Lieberman BH Koller JN Snouwaert (2002) ArticleTitleAlterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function Brain Res 951 166–176 Occurrence Handle12270494 Occurrence Handle10.1016/S0006-8993(02)03156-6 Occurrence Handle1:CAS:528:DC%2BD38Xnt1ajtbs%3D

    Article  PubMed  CAS  Google Scholar 

  • GE Duncan SS Moy A Perez DM Eddy WM Zinzow JA Lieberman JN Snouwaert BH Koller (2004) ArticleTitleDeficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function Behav Brain Res 153 507–519 Occurrence Handle15265649 Occurrence Handle10.1016/j.bbr.2004.01.008 Occurrence Handle1:CAS:528:DC%2BD2cXlsl2jt7g%3D

    Article  PubMed  CAS  Google Scholar 

  • GE Duncan SS Moy JA Lieberman BH Koller (2006) ArticleTitleEffects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function Psychopharmacology 184 190–200 Occurrence Handle16362405 Occurrence Handle10.1007/s00213-005-0214-1 Occurrence Handle1:CAS:528:DC%2BD28XksVOiuw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • NB Farber MT Price J Labruyere J Nemnich H St. Peter DF Wozniak JW Olney (1993) ArticleTitleAntipsychotic drugs block phencyclidine receptor-mediated neurotoxicity Biol Psychiat 34 119–121 Occurrence Handle8373932 Occurrence Handle10.1016/0006-3223(93)90265-F Occurrence Handle1:CAS:528:DyaK2cXhsFemtrw%3D

    Article  PubMed  CAS  Google Scholar 

  • NB Farber SH Kim K Dikranian XP Jiang C Heinkel (2002) ArticleTitleReceptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity Mol Psychiat 7 32–43 Occurrence Handle10.1038/sj/mp/4000912 Occurrence Handle1:CAS:528:DC%2BD38XhsVGmu70%3D

    Article  CAS  Google Scholar 

  • RL Fradley GF O’Meara RJ Newman A Andrieux D Job DS Reynolds (2005) ArticleTitleSTOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating Behav Brain Res 163 257–264 Occurrence Handle16046005 Occurrence Handle10.1016/j.bbr.2005.05.012 Occurrence Handle1:CAS:528:DC%2BD2MXns1Wjsbs%3D

    Article  PubMed  CAS  Google Scholar 

  • KBJ Franklin G Paxinos (1997) The mouse brain in stereotaxic coordinates Academic Press San Diego

    Google Scholar 

  • R Greene (2001) ArticleTitleCircuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia Hippocampus 11 569–577 Occurrence Handle11732709 Occurrence Handle10.1002/hipo.1072 Occurrence Handle1:CAS:528:DC%2BD3MXptVKrs7c%3D

    Article  PubMed  CAS  Google Scholar 

  • HC Grunze DG Rainnie ME Hasselmo E Barkai EF Hearn RW McCarley RW Greene (1996) ArticleTitleNMDA-dependent modulation of CA1 local circuit inhibition J Neurosci 16 2034–2043 Occurrence Handle8604048 Occurrence Handle1:CAS:528:DyaK28XhvVGnsrs%3D

    PubMed  CAS  Google Scholar 

  • U Heresco-Levy (2003) ArticleTitleGlutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality Prog Neuro psychopharmacol Biol Psychiat 27 1113–1123 Occurrence Handle10.1016/j.pnpbp.2003.09.007 Occurrence Handle1:CAS:528:DC%2BD3sXpt1SgtL0%3D

    Article  CAS  Google Scholar 

  • DC Javitt SR Zukin (1991) ArticleTitleRecent advances in the phencyclidine model of schizophrenia Am J Psychiat 148 1301–1308 Occurrence Handle1654746 Occurrence Handle1:STN:280:By6A2sjosFY%3D

    PubMed  CAS  Google Scholar 

  • S Kapur SC Vanderspek BA Brownlee JN Nobrega (2003) ArticleTitleAntipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy J Pharmacol Exp Ther 305 625–631 Occurrence Handle12606608 Occurrence Handle10.1124/jpet.102.046987 Occurrence Handle1:CAS:528:DC%2BD3sXjt12murk%3D

    Article  PubMed  CAS  Google Scholar 

  • JH Krystal LP Karper JP Seibyl GK Freeman R Delaney JD Bremner GR Heninger MB Bowers SuffixJr DS Charney (1994) ArticleTitleSubanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiat 51 199–214 Occurrence Handle8122957 Occurrence Handle1:CAS:528:DyaK2cXkslemtrY%3D

    PubMed  CAS  Google Scholar 

  • A Kurumaji DG Nehls CK Park J McCulloch (1989) ArticleTitleEffects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use Brain Res 496 268–284 Occurrence Handle2553203 Occurrence Handle10.1016/0006-8993(89)91074-3 Occurrence Handle1:CAS:528:DyaL1MXlvVOnsro%3D

    Article  PubMed  CAS  Google Scholar 

  • AC Lahti B Koffel D LaPorte CA Tamminga (1995) ArticleTitleSubanesthetic doses of ketamine stimulate psychosis in schizophrenia Neuropsychopharmacology 13 9–19 Occurrence Handle8526975 Occurrence Handle10.1038/sj.npp.1380271 Occurrence Handle1:CAS:528:DyaK2MXns1Kksbs%3D

    Article  PubMed  CAS  Google Scholar 

  • AC Lahti MA Weiler MB Tamara A Parwani CA Tamminga (2001) ArticleTitleEffects of ketamine in normal and schizophrenic volunteers Neuropsychopharmacology 25 455–467 Occurrence Handle11557159 Occurrence Handle10.1016/S0893-133X(01)00243-3 Occurrence Handle1:CAS:528:DC%2BD3MXms12msLY%3D

    Article  PubMed  CAS  Google Scholar 

  • DS Lorrain CS Baccei LJ Bristow JJ Anderson MA Varney (2003) ArticleTitleEffects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268 Neuroscience 117 697–706 Occurrence Handle12617973 Occurrence Handle10.1016/S0306-4522(02)00652-8 Occurrence Handle1:CAS:528:DC%2BD3sXhs1Khsrs%3D

    Article  PubMed  CAS  Google Scholar 

  • WHW Lunn DD Schoepp DO Calligaro RT Vasileff LJ Heinz CR Salhoff PJ Omalley (1992) ArticleTitleDl-tetrazol-5-ylglycine, a highly potent NMDA agonist – its synthesis and NMDA receptor efficacy J Med Chem 35 4608–4612 Occurrence Handle1361579 Occurrence Handle10.1021/jm00102a015 Occurrence Handle1:CAS:528:DyaK3sXntlCl

    Article  PubMed  CAS  Google Scholar 

  • S Miyamoto JN Leipzig JA Lieberman GE Duncan (2000) ArticleTitleEffects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice Neuropsychopharmacology 22 400–412 Occurrence Handle10700659 Occurrence Handle10.1016/S0893-133X(99)00127-X Occurrence Handle1:CAS:528:DC%2BD3cXhsVajsbk%3D

    Article  PubMed  CAS  Google Scholar 

  • S Miyamoto JN Snouwaert BH Koller SS Moy JA Lieberman GE Duncan (2004) ArticleTitleAmphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunction Neuropsychopharmacology 29 2180–2188 Occurrence Handle15467708 Occurrence Handle10.1038/sj.npp.1300548 Occurrence Handle1:CAS:528:DC%2BD2cXhtVSmsrfI

    Article  PubMed  CAS  Google Scholar 

  • B Moghaddam B Adams A Verman D Daly (1997) ArticleTitleActivation of glutamatergic neurotransmission by ketamine – a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J Neurosci 17 2921–2927 Occurrence Handle9092613 Occurrence Handle1:CAS:528:DyaK2sXisValurk%3D

    PubMed  CAS  Google Scholar 

  • AR Mohn RR Gainetdinov MG Caron BH Koller (1999) ArticleTitleMice with reduced NMDA receptor expression display behaviors related to schizophrenia Cell 98 427–436 Occurrence Handle10481908 Occurrence Handle10.1016/S0092-8674(00)81972-8 Occurrence Handle1:CAS:528:DyaK1MXlslWmsb0%3D

    Article  PubMed  CAS  Google Scholar 

  • SS Moy A Perez BH Koller GE Duncan (2006) ArticleTitleAmphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function Brain Res 1089 186–194 Occurrence Handle16638606 Occurrence Handle10.1016/j.brainres.2006.03.073 Occurrence Handle1:CAS:528:DC%2BD28XltFCrt7c%3D

    Article  PubMed  CAS  Google Scholar 

  • M Nilsson KR Markinhuhta ML Carlsson (2006) ArticleTitleDifferential effects of classical neuroleptics and a newer generation antipsychotics on the MK-801 induced behavioural primitivization in mouse Prog Neuropsychopharmacol Biol Psychiat 30 521–530 Occurrence Handle10.1016/j.pnpbp.2005.11.010 Occurrence Handle1:CAS:528:DC%2BD28Xjs1aitLc%3D

    Article  CAS  Google Scholar 

  • I Ninan KE Jardemark RY Wang (2003) ArticleTitleDifferential effects of atypical and typical antipsychotic drugs on N-methyl-D-aspartate- and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex Synapse 48 66–79 Occurrence Handle12619040 Occurrence Handle10.1002/syn.10189 Occurrence Handle1:CAS:528:DC%2BD3sXivFWhsLk%3D

    Article  PubMed  CAS  Google Scholar 

  • SY Sakurai JHJ Cha JB Penney AB Young (1991) ArticleTitleRegional distribution and properties of [H-3] Mk-801 binding-sites determined by quantitative autoradiography in rat-brain Neuroscience 40 533–543 Occurrence Handle2027471 Occurrence Handle10.1016/0306-4522(91)90139-F Occurrence Handle1:CAS:528:DyaK3MXhtlKmsr4%3D

    Article  PubMed  CAS  Google Scholar 

  • DD Schoepp CL Smith D Lodge JD Millar JD Leander AI Sacaan WHW Lunn (1991) ArticleTitleD,L-(Tetrazol-5-Yl) Glycine – a novel and highly potent NMDA receptor agonist Eur J Pharmacol 203 237–243 Occurrence Handle1686860 Occurrence Handle10.1016/0014-2999(91)90719-7 Occurrence Handle1:CAS:528:DyaK38XjsV2gsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • M Sheng ME Greenberg (1990) ArticleTitleThe regulation and function of C-Fos and other immediate early genes in the nervous-system Neuron 4 477–485 Occurrence Handle1969743 Occurrence Handle10.1016/0896-6273(90)90106-P Occurrence Handle1:CAS:528:DyaK3MXhs1WhsbY%3D

    Article  PubMed  CAS  Google Scholar 

  • NR Swerdlow VP Bakshi MA Geyer (1996) ArticleTitleSeroquel restores sensorimotor gating in phencyclidine-treated rats J Pharmacol Exp Ther 279 1290–1299 Occurrence Handle8968353 Occurrence Handle1:CAS:528:DyaK2sXmslKk

    PubMed  CAS  Google Scholar 

  • FI Tarazi WJ Florijn I Creese (1996) ArticleTitleRegulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics Psychopharmacology 128 371–379 Occurrence Handle8986008 Occurrence Handle10.1007/s002130050147 Occurrence Handle1:CAS:528:DyaK2sXms12nsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • RY Wang X Liang (1998) ArticleTitleM100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice Neuropsychopharmacology 19 74–85 Occurrence Handle9608579 Occurrence Handle10.1016/S0893-133X(98)00003-7 Occurrence Handle1:CAS:528:DyaK1cXjsVOqsr0%3D

    Article  PubMed  CAS  Google Scholar 

  • M Wittmann MJ Marino DA Henze GR Seabrook PJ Conn (2005) ArticleTitleClozapine potentiation of N-methyl-D-aspartate receptor currents in the nucleus accumbens: role of NR2B and protein kinase A/Src kinases J Pharmacol Exp Ther 313 594–603 Occurrence Handle15659539 Occurrence Handle10.1124/jpet.104.080200 Occurrence Handle1:CAS:528:DC%2BD2MXktFems7g%3D

    Article  PubMed  CAS  Google Scholar 

  • W Zhang FP Bymaster (1999) ArticleTitleThe in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D-1, D-2, D-3, 5HT(2A) and muscarinic receptors Psychopharmacology 141 267–278 Occurrence Handle10027508 Occurrence Handle10.1007/s002130050834 Occurrence Handle1:CAS:528:DyaK1MXotlCnug%3D%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, CB 7090 University of North Carolina, Chapel Hill, NC, U.S.A.

    K. Inada, J. S. Farrington, S. S. Moy, B. H. Koller & G. E. Duncan

Authors
  1. K. Inada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. S. Farrington
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. S. Moy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. H. Koller
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. E. Duncan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inada, K., Farrington, J., Moy, S. et al. Assessment of NMDA receptor activation in vivo by Fos induction after challenge with the direct NMDA agonist (tetrazol-5-yl)glycine: effects of clozapine and haloperidol. J Neural Transm 114, 899–908 (2007). https://doi.org/10.1007/s00702-007-0628-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-007-0628-5

Search

Navigation